VALLEY NATIONAL ADVISERS INC – Regeneron Pharmaceuticals, Inc. Transaction History
VALLEY NATIONAL ADVISERS INC portfolio value:
$986,000
portfolio value
VALLEY NATIONAL ADVISERS INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +3.88% | 51 shares | 188K | $688.87 | 1.36K |
Q2 2022 | share | Increase | +2.26% | 29 shares | -100K | $591.13 | 1.31K |
Q1 2022 | share | Increase | +2.80% | 35 shares | 109K | $698.42 | 1.28K |
Q4 2021 | share | Increase | +0.16% | 2 shares | 34K | $642.51 | 1.25K |
Q3 2021 | share | Increase | +13.15% | 145 shares | 139K | $605.18 | 1.24K |
Q2 2021 | share | Increase | +74.53% | 471 shares | 317K | $558.54 | 1.10K |
Q1 2021 | share | Increase | +2.10% | 13 shares | 0 | $473.14 | 632 |
Q4 2020 | share | Increase | +32.55% | 152 shares | 38K | $483.11 | 619 |
Q3 2020 | share | Increase | +22.89% | 87 shares | 24K | $559.78 | 467 |
Q2 2020 | share | Increase | +55.74% | 136 shares | 118K | $623.65 | 380 |
Q1 2020 | share | Decrease | -52.06% | -265 shares | -72K | $488.29 | 244 |
Q4 2019 | share | 0.00% | 0 shares | 50K | $375.48 | 509 | |
Q3 2019 | share | Increase | +2.00% | 10 shares | -15K | $277.4 | 509 |
Q2 2019 | share | Increase | +46.76% | 159 shares | 16K | $313 | 499 |
Q1 2019 | share | Decrease | -31.86% | -159 shares | -46K | $410.62 | 340 |
Q4 2018 | share | Increase | +1.84% | 9 shares | -12K | $373.5 | 499 |
Q3 2018 | share | 0.00% | 0 shares | 29K | $404.04 | 490 | |
Q2 2018 | share | Increase | +13.69% | 59 shares | 21K | $344.99 | 490 |
Q1 2018 | share | Increase | +22.79% | 80 shares | 16K | $344.36 | 431 |
Q4 2017 | share | Decrease | -2.50% | -9 shares | -29K | $375.96 | 351 |
Q3 2017 | share | Increase | +2300.00% | 345 shares | 154K | $447.12 | 360 |
Q2 2017 | share | 0.00% | 0 shares | 1K | $491.14 | 15 | |
Q1 2017 | share | 0.00% | 0 shares | 0 | $387.51 | 15 | |
Q4 2016 | share | 0.00% | 0 shares | 0 | $367.09 | 15 | |
Q3 2016 | share | 0.00% | 0 shares | 1K | $402.02 | 15 | |
Q2 2016 | share | 0.00% | 0 shares | 0 | $349.23 | 15 | |
Q1 2016 | share | 0.00% | 0 shares | -3K | $360.44 | 15 |